...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration.
【24h】

Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration.

机译:在全天候口服THC施用后,在口服液中处置大麻素。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Oral fluid, a promising alternative matrix for drug monitoring in clinical and forensic investigations, offers noninvasive sample collection under direct observation. Cannabinoid distribution into oral fluid is complex and incompletely characterized due to the lack of controlled drug administration studies. METHODS: To characterize cannabinoid disposition in oral fluid, we administered around-the-clock oral Delta(9)-tetrahydrocannabinol (THC) (Marinol) doses to 10 participants with current daily cannabis use. We obtained oral fluid samples (n=440) by use of Quantisal collection devices before, during, and after 37 20-mg THC doses over 9 days. Samples were extracted with multiple elution solvents from a single SPE column and analyzed by 2-dimensional GC-MS with electron-impact ionization for THC, 11-hydroxy-THC (11-OH-THC), cannabidiol, and cannabinol and negative chemical ionization for 11-nor-9-carboxy-THC (THCCOOH). Linear ranges were 0.5-50 microg/L, with the exception of cannabinol (1-50 microg/L) and THCCOOH (7.5-500 ng/L). RESULTS: THCCOOH was the most prevalent analyte in 432 samples (98.2%), with concentrations up to 1117.9 ng/L. In contrast, 11-OH-THC was not identified in any sample; cannabidiol and cannabinol were quantified in 3 and 8 samples, respectively, with maximum concentrations of 2.1 and 13 microg/L. THC was present in only 20.7% of samples, with highest concentrations near admission (median 4.2 microg/L, range 0.6-481.9) from previously self-administered smoked cannabis. CONCLUSIONS: Measurement of THCCOOH in OF not only identifies cannabis exposure, but also minimizes the possibility of passive inhalation. THCCOOH may be a better analyte for detection of cannabis use.
机译:背景:口服液是在临床和法医研究中用于药物监测的一种有希望的替代基质,可在直接观察下提供无创样品采集。由于缺乏受控的药物管理研究,大麻素在口腔液中的分布复杂且特征不完整。方法:为了表征口服液中大麻素的分布,我们向每天使用大麻的10名参与者提供了全天候口服Delta(9)-四氢大麻酚(THC)(Marinol)剂量。我们在9天内服用37毫克20毫克四氢大麻酚之前,之中和之后,使用Quantisal采集设备获得了口服液样本(n = 440)。使用多种洗脱溶剂从单个SPE色谱柱中提取样品,并通过二维电子气相色谱(GC-MS)对THC,11-羟基-THC(11-OH-THC),大麻二酚,大麻酚和负化学电离进行电子碰撞电离分析11-nor-9-羧基-THC(THCCOOH)。线性范围为0.5-50 microg / L,除了大麻酚(1-50 microg / L)和THCCOOH(7.5-500 ng / L)。结果:THCCOOH是432个样品中最普遍的分析物(98.2%),浓度高达1117.9 ng / L。相反,在任何样品中均未鉴定出11-OH-THC。大麻酚和大麻酚分别在3和8个样品中定量,最大浓度为2.1和13 microg / L。 THC仅存在于20.7%的样品中,其最高浓度接近于以前自我管理的熏制大麻的入场浓度(中值4.2微克/升,范围0.6-481.9)。结论:在OF中测量THCCOOH不仅可以识别大麻暴露,而且可以最大程度地减少被动吸入的可能性。 THCCOOH可能是检测大麻使用情况的更好分析物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号